Header Image for Sonata vs Restoril

Sonata vs Restoril

Listen to the article instead of reading through it.
0:00

Overview

Sonata Overview

Sonata Details

Restoril Overview

Restoril Details

Comparative Analysis

Sonata Prescription Information

Restoril Prescription Information

Sonata Side Effects

Restoril Side Effects

Safety Information

Cost Analysis

Market Analysis

Conclusion

Introduction

For patients struggling with insomnia or other sleep-related disorders, certain medications that influence the central nervous system can assist in managing symptoms and promoting restful sleep. Sonata and Restoril are two such drugs commonly prescribed for these conditions. Both affect neurotransmitter activity to induce drowsiness and encourage sound sleep, yet they work in slightly different ways. Sonata (zaleplon) is a non-benzodiazepine hypnotic from the pyrazolopyrimidine class, acting mainly on GABA-A receptors to promote relaxation and sleep onset. On the other hand, Restoril (temazepam), classified as a benzodiazepine, also increases GABA's inhibitory effects but has a longer half-life than Sonata; thus it not only helps individuals fall asleep but also maintains this state throughout the night.

Sonata vs Restoril Side By Side

AttributeSonataRestoril
Brand NameSonataRestoril
ContraindicationsShould not be taken with alcohol or substances that depress the central nervous system.Should not be taken with alcohol or substances that depress the central nervous system.
CostFor brand name: around $213 for 30 capsules (10 mg). For generic (Zaleplon): ranges from $0.76 to $2.20 per day.For brand name: approximately $209 for 30 capsules (15 mg). For generic (Temazepam): averages between $.50 and $1.60 per day.
Generic NameZaleplonTemazepam
Most Serious Side EffectAbnormal thoughts and behavior changes, signs of allergic reactions, changes in vision, irregular heartbeat, hyponatremia, severe nervous system reaction.Signs of a severe allergic reaction, unusual behavior or mood changes, confusion or hallucinations, agitation and increased anxiety, new or worsening depression, suicidal thoughts or actions, memory problems, slowed breathing.
Severe Drug InteractionsCan intensify drowsiness when taken with other substances that depress the central nervous system.Can intensify drowsiness when taken with other substances that depress the central nervous system.
Typical Dose5–20 mg/night, with 10 mg/night being sufficient for most people.Begins with a low dosage of 7.5 mg/day, can be increased to 15-30 mg/day.

What is Sonata?

Zaleplon (the generic name for Sonata) was a significant advancement in the class of drugs known as nonbenzodiazepine hypnotics. Zaleplon was first approved by the FDA in 1999 and is prescribed primarily for insomnia, particularly when difficulty falling asleep is the main symptom. Unlike traditional benzodiazepines, Sonata acts specifically on receptors associated with sleep while having minimal effects on other areas of brain function. This specificity results in it having fewer side effects than older sleep medications.

In contrast, Temazepam (Restoril), a member of the benzodiazepine class of drugs which were among the initial treatments for sleeping disorders before nonbenzodiazepines like Sonata became available, has broader neurological impacts and could potentially lead to more extensive side effects such as morning grogginess or dependence issues over extended use. Both are effective at promoting sleep but their appropriateness can vary depending on individual patient circumstances and needs.

What conditions is Sonata approved to treat?

Sonata is approved for the treatment of certain sleep disorders:

  • Short-term treatment of insomnia
  • Difficulty falling asleep

Restoril, on the other hand, is also a medication to treat sleep disturbances:

  • Insomnia (both difficulty falling asleep and staying asleep)
  • Anxiety or stress-induced insomnia

How does Sonata help with these illnesses?

Sonata helps manage insomnia by acting on the gamma-aminobutyric acid (GABA) receptors in the brain. It is a sedative-hypnotic that slows activity in the brain to allow sleep by enhancing GABA, an inhibitory neurotransmitter that reduces neuronal excitability throughout the nervous system. Sonata works quickly to initiate sleep but has a short duration of action and thus may not maintain sleep for those who have problems with middle-of-the-night or early morning awakenings.

On the other hand, Restoril also exerts its effects through GABA receptors; however, it has a longer half-life than Sonata and hence can help maintain sleep throughout the night. Still, due to this prolonged action, Restoril may cause residual daytime sedation or grogginess upon awakening.

Both medications are beneficial in managing insomnia but their choice depends primarily on whether your problem involves difficulty falling asleep (where Sonata might be more suitable), or maintaining sleep (in which case Restoril could be more effective).

What is Restoril?

Restoril is a brand name for temazepam, which is a benzodiazepine, meaning it increases the levels of gamma-aminobutyric acid (GABA) in the brain by enhancing its effects. It also has some muscle relaxant and anticonvulsant properties. Temazepam was first approved by the FDA in 1981. As temazepam is not a barbiturate sedative, it does not have an effect on certain enzymes in the liver that metabolize drugs. Its lack of action on these enzymes means that its side-effect profile is different to that of barbiturates; particularly, it does not cause significant drug interactions and presents less risk for overdose (common risks associated with barbiturates). The effects on GABA can be beneficial for promoting sleep and reducing anxiety symptoms, especially in patients who do not respond well to other types of sedatives such as Sonata.

What conditions is Restoril approved to treat?

Restoril is a medication approved for use for the following conditions:

  • Insomnia, especially where falling asleep or staying asleep are prominent symptoms
  • Short-term treatment of sleep disturbances, such as those caused by stress and transient insomnia.

How does Restoril help with these illnesses?

Restoril, also known as Temazepam, is a benzodiazepine medication primarily used for the treatment of insomnia. It works by augmenting the effects of GABA, an inhibitory neurotransmitter in the brain that helps to slow down activity and induce sleepiness or calmness. This drug not only aids in falling asleep but also helps you stay asleep throughout the night due to its longer half-life compared to other similar medications like Sonata (Zaleplon). Restoril's action on GABA receptors provides a sedative effect which can help relieve symptoms of anxiety as well. Its efficacy may vary from person to person and it is generally prescribed when non-pharmacological interventions fail to provide sufficient sleep relief or if insomnia symptoms are severe enough to interfere with daily functioning.

How effective are both Sonata and Restoril?

Both zaleplon (Sonata) and temazepam (Restoril) are well-established medications for managing short-term insomnia. They were approved by the FDA only three years apart, with temazepam receiving approval in 1981 and zaleplon in 1999. While both function as hypnotics, they belong to different drug classes: Sonata is a nonbenzodiazepine sedative-hypnotic while Restoril is a benzodiazepine.

Several clinical trials have compared the efficacy of Sonata and Restoril directly. In one such double-blind study conducted in 2004, it was found that both drugs significantly reduced sleep latency (the time taken to transition from full wakefulness to sleep) and improved overall sleep quality when compared to placebo controls. However, neither drug demonstrated superiority over the other across several key metrics used to measure improvements in sleep.

The safety profiles of Sonata and Restoril are also quite similar, with the most common side effects being drowsiness or impaired motor function upon waking - which can be largely mitigated if patients ensure they're able to get an adequate amount of sleep after taking either medication.

A comprehensive review published in 2016 reiterated these findings regarding their comparable efficacy. However, due to its shorter half-life – typically around just one hour compared with temazepam's six-to-eight hours – Sonata may be slightly better suited for patients who need help falling asleep but do not suffer from frequent awakenings during the night or early morning hours.

Temazepam on the other hand has a longer duration of action making it more suitable for those struggling with maintaining uninterrupted slumber throughout the night. Yet like all benzodiazepines there's potential risk involved with long-term use including dependence issues inducing withdrawal symptoms if discontinued abruptly; hence should never exceed recommended dosage without consulting your healthcare provider first.

abstract image of a researcher studying a bottle of drug.

Find Top Clinical Trials

Choose from over 30,000 active clinical trials.

At what dose is Sonata typically prescribed?

Oral dosages of Sonata range from 5–20 mg/night, but studies have indicated that 10 mg/night is sufficient for treating insomnia in most people. Elderly or debilitated patients may be started on 5 mg/night. In either population, dosage can be increased after a few days if there is no response. The maximum dosage that should not be exceeded in any case is 20 mg/night. On the other hand, Restoril has an oral dosage range of 7.5-30mg before bedtime but usually, a dose of around 15mg at night proves effective enough to treat sleep disorders in adults while elderly or debilitated patients are recommended a starting dose of only 7.5mg per night with careful monitoring for side effects and effectiveness.

At what dose is Restoril typically prescribed?

Restoril treatment typically begins with a low dosage of 7.5 mg/day, taken orally just before bedtime. Depending on the patient's response and tolerance to the drug, this dose could be increased to 15-30 mg/day, given in a single dose right before bedtime. It is important not to exceed the maximum recommended daily dosage of 30 mg. If after some time there is no significant improvement in sleep patterns or if symptoms persist, it might necessitate an evaluation by your physician for possible dosage adjustment or switch of medication.

What are the most common side effects for Sonata?

Common side effects of Sonata (Zaleplon) may include:

  • Headache
  • Dizziness or lightheadedness
  • Unusual weakness or feeling of fatigue, asthenia
  • Nervousness
  • Daytime drowsiness, somnolence
  • A "hangover" effect (residual sleepiness and impaired cognition)
  • Abnormal dreams or nightmares -Dry mouth -Stomach pain, nausea, dyspepsia
    -Memory problems

On the other hand, Restoril (Temazepam), another type of sedative medication used for insomnia treatment may cause:

-Nausea and vomiting
-Daytime drowsiness/sleepy/drowsy feeling
-Fatigue/feeling tired;
-Loss of coordination; -Dizziness; -A headache;
-Nervousness; -Dry mouth.

abstract image of a patient experiencing side effect

Are there any potential serious side effects for Sonata?

It's important to be aware of potential side effects while taking Sonata or Restoril. Although it is rare, some serious side effects may occur:

  • Abnormal thoughts and behavior changes such as aggressiveness, abnormal outgoingness, hallucinations, confusion
  • Signs of allergic reactions: itching or hives; swelling in your face or hands; swelling or tingling in your mouth or throat; chest tightness; difficulty breathing
  • Changes in vision like blurred vision, trouble focusing
  • Irregular heartbeat that feels too fast or too slow. This could also include fluttering sensations in the chest.
  • Hyponatremia - low sodium levels which can cause symptoms such as headache, slurred speech, severe weakness, vomiting and unsteady movements
  • Severe nervous system reaction - muscle stiffness due to tetany (involuntary contraction of muscles), high fever with sweating and tremors can occur.

If you experience any unusual symptoms while on these medications including nausea and diarrhea which might indicate serotonin syndrome (although this is highly unlikely), seek medical attention immediately.

What are the most common side effects for Restoril?

Restoril, a commonly prescribed sleep aid, can cause the following side effects:

  • Dry mouth or changes in appetite
  • Nausea, vomiting and stomach discomfort
  • Dizziness or lightheadedness
  • Daytime drowsiness or "hangover" feeling
  • Feeling of nervousness
  • Headache or fatigue
  • Coordination problems and potential for falls
    Please note that while Restoril is effective for insomnia, it's not meant for long-term use due to its potential for dependence. If you experience any severe symptoms like confusion, hallucinations, agitation or memory issues after taking Restoril, seek medical help immediately. Always consult with your healthcare professional before starting any new medication.

Are there any potential serious side effects for Restoril?

Restoril can have serious side effects in some instances. If these occur, immediate medical attention is required:

  • Signs of a severe allergic reaction: hives, difficulty breathing, swelling of your face, lips, tongue or throat
  • Unusual behavior or mood changes
  • Confusion or hallucinations
  • Agitation and increased anxiety
  • New or worsening depression
  • Suicidal thoughts or actions
  • Memory problems such as sleep-related activities like driving or eating (sleep-walking)
  • Slowed breathing to the point where long pauses between breaths are noticed

If any of these symptoms are experienced while taking Restoril, stop using the drug immediately and consult with a healthcare provider.

Contraindications for Sonata and Restoril?

Both Sonata and Restoril, along with most other sleep medications, may worsen symptoms of insomnia or cause unusual behavior during sleep in some people. If you notice your sleeping patterns worsening, or an increase in episodes of sleep walking, nightmares, agitation or hallucinations while using these drugs, please seek immediate medical attention.

Neither Sonata nor Restoril should be taken if you are consuming alcohol or have been taking any substances that depress the central nervous system (such as opioids). Both these medicines can intensify the drowsiness induced by these substances and lead to potentially dangerous side effects such as slowed breathing and heart rate. Always inform your physician which medications you are taking; substances that depress the central nervous system will require a period of clearance from your body to prevent harmful interactions with Sonata and Restoril.

How much do Sonata and Restoril cost?

For the brand name versions of these drugs:

  • The price for 30 capsules of Sonata (10 mg) averages around $213, which works out to about $7/day.
  • The price for 30 capsules of Restoril (15 mg) is approximately $209, working out to roughly $7/day.

Thus, if you're taking a single dose daily, both brand-name Sonata and Restoril are similar in cost on a per-day treatment basis. However, it's important to note that cost should not be the primary factor in determining which medication is best suited for you.

For the generic versions of these medications - Zaleplon (Sonata) and Temazepam (Restoril), costs are significantly lower:

  • Zaleplon is available with approximate costs ranging from $0.76 to $2.20 per day depending on your dosage which can vary between 5mg and 20mg.
  • Temazepam comes with an average expense lying between $.50 and $1.60 per day based on typical dosages varying from 7.5mg to 45mg.

Again, while generic versions offer substantial savings over their branded counterparts, efficacy and personal tolerance should guide your decision rather than mere pricing considerations alone.

Popularity of Sonata and Restoril

Zaleplon, under the brand name Sonata, was estimated to have been prescribed to about 400,000 people in the US in 2020. Zaleplon accounted for approximately 1% of prescription sleep aids. It's a non-benzodiazepine hypnotic that helps induce sleep quickly and is most effective when taken immediately before bedtime.

Temazepam, also known as Restoril among other brand names, was prescribed to just over 3 million individuals in the USA during the same time frame. This equates to around 7% of all prescriptions for insomnia medication. Temazepam belongs to a class of drugs called benzodiazepines which reduce neural activity promoting sleep but it tends towards longer duration action than zaleplon and can contribute more significantly toward next-day grogginess or "hangover" effects.

Both medications have maintained relatively stable prescription rates over the past decade with slight declines likely due to increased awareness regarding potential dependency issues associated with long-term use of these types of sedative-hypnotics.

Conclusion

Both Sonata (zaleplon) and Restoril (temazepam) have extensive records of usage in patients with insomnia, and are supported by numerous clinical studies indicating that they promote sleep more effectively than placebo treatments. In some cases, these drugs may be combined, but this is subject to careful consideration by a physician as they can interact with each other. Due to their different mechanisms of action - Sonata primarily shortens the time it takes to fall asleep while Restoril helps maintain sleep throughout the night - they tend to be prescribed under different circumstances.

Both medications are available in generic form, which represents significant cost savings especially for those who must pay out of pocket. Both zaleplon and temazepam may require an adjustment period; meaning that effects might not be noticeable right away.

The side effect profile is similar between the two drugs; both being generally well-tolerated but with Restoril possibly causing more daytime drowsiness than Sonata due to its longer half-life. As for all sleeping aids, patients should use them responsibly and seek medical help immediately if dependence or withdrawal symptoms begin to develop.

Refrences

  • Moore, K. A., Zemrus, T. L., Ramcharitar, V., Levine, B., & Fowler, D. R. (2003, July). Mixed drug intoxication involving zaleplon (“Sonata®”). Forensic Science International. Elsevier BV.http://doi.org/10.1016/s0379-0738(03)00130-0